维普中文期刊产品整合服务
227篇 您的检索式:作者名="Lau WC"
    题名 作者 年代 出处 被引量
1Validation of the Physical Activity Questionnaire for Older Children(PAQ-C) among Chinese Children显示文摘Objective This study initially validates the Chinese version of the Physical Activity Questionnaire for Older Children(PAQ-C), which has been identified as a potentially valid instrument to assess moderate-to-vigorous physical activity(MVPA) in children among diverse racial groups. Methods The psychometric properties of the PAQ-C with 742 Hong Kong Chinese children were assessed with the scale's internal consistency, reliability, test-retest reliability, confirmatory factory analysis(CFA) in the overall sample, and multistep invariance tests across gender groups as well as convergent validity with body mass index(BMI), and an accelerometry-based MVPA. Results The Cronbach alpha coefficient(α=0.79), composite reliability value(ρ=0.81), and the intraclass correlation coefficient(α=0.82) indicate the satisfactory reliability of the PAQ-C score. The CFA indicated data fit a single factor model, suggesting that the PAQ-C measures only one construct, on MVPA over the previous 7 days. The multiple-group CFAs suggested that the factor loadings and variances and covariances of the PAQ-C measurement model were invariant across gender groups. The PAQ-C score was related to accelerometry-based MVPA(r=0.33) and inversely related to BMI(r=-0.18). Conclusion This study demonstrates the reliability and validity of the PAQ-C in Chinese children.WANG Jing Jing BARANOWSKI Tom LAU WC Patrick CHEN Tzu An PITKETHLY Amanda Jane 2016Biomedical and Environmental Sciences2016,29,3:7
2Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance显示文摘Lau WC Gurbel PA Watkins PB 2004Circulation2004,109,:1
3Rapid aneuploidy screening (FISH or QF-PCR ): the changing scene in prenatal diagnosis? 显示文摘Leung WC Lau ET Lao T 2004Expert Rev Mol Diagn2004,4,3:1
4Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation : a new drug-drug interaction 显示文摘Lau WC Waskell LA Watkins PB 2003Circulation2003,107,:1
5Controversies in antiplatelet therapy for patients with cardiovascular disease 显示文摘Bates ER Lau WC 2005Circulation2005,111,7:1
6Contribution of he- patic cytochrome P450 3A4 metabolic activity to the phe- nomenon of clopidogrel resistance显示文摘Lau WC Gurbel PA Watkins PB 2004Circulation2004,109,2:1
7Atorvastatin reducesthe ability of clopidogrel to inhibit platelet aggregation : a newdrug-drug interaction 显示文摘Lau WC Waskell LA Watkins PB 2003Circulation2003,107,1:1
8Contribution of hepatic cytochrome p450 3A4 metabolic activity to the phenomenon of clopidogrel resistance显示文摘Lau WC Gurbel PA Watkins PB 2004Circulation2004,109,2:1
9Contribution of he- patic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance 显示文摘Lau WC Gurbel PA Watkins PB 2004Circulation2004,109,2:1
10Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation:a new drug-drug interaction显示文摘LAU WC WASKELL LA WATKINS PB 2003Circulation2003,107,1:1
11Contribution of hepatic cy- tochrome P450 3A4 metabolic activity to the phenomenon of clopi- dog relresistance 显示文摘Lau WC Gurbel PA Watkins PB 2004Circulation2004,109,2:1
12Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance 显示文摘Lau WC Gurbel PA Watkins PB 2004Circulation2004,109,:1
13Contribution of hepatic cytochrome P 450 3A4 metabolic activity to the phenomenon of clopidogrel resistance显示文摘Lau WC Gurbel PA Watkins PB 2004Circulation2004,109,2:1
14Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation : a new drug-drug interaction 显示文摘Lau WC Waskell LA Watkins PB 2003Circulation2003,107,1:1
15Diagnostic power of various computed tomography signs in diagnosing acute appendicitis显示文摘Lai V Chan WC Lau HY 2012Clin Imaging2012,36,1:1
16Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance 显示文摘Lau WC Gurbel PA Watkins PB 2004Circulation2004,109,2:1
17HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a forHBeAg-positive chronic hepatitis B 显示文摘Fried MW Piratvisuth T Lau GK Marcellin P Chow WC Cooksley G Luo KX Paik SW Liaw YF Button P Popescu M 2008Hepatology2008,47,2:1
18Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance 显示文摘Lau WC Gurbel PA Watkins PB 2004Circulation2004,109,2:1
19Clinical significance of the atorvastatin-clopidogrel drug-drug interaction显示文摘Lau WC Carville DG Bates ER 2004Circulation2004,110,6:1
20Clopidogrel nonresponders discovered during point-of-care platelet aggregation testing显示文摘Lau WC Neer CJ Watkins PB 2003J Am Coil Cardiol2003,41,:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费